Elanco Animal Health Incorporated (NYSE:ELAN) Q2 2022 Earnings Conference Call August 8, 2022 8:00 AM ET

Company Participants

Katy Grissom - Head of Investor Relations

Jeff Simmons - President & Chief Executive Officer

Todd Young - Chief Financial Officer

Conference Call Participants

Erin Wright - Morgan Stanley

Michael Ryskin - Bank of America

Chris Schott - JPMorgan

Jon Block - Stifel

Mike DiFiore - Evercore ISI

Nathan Rich - Goldman Sachs

Christine Raines - William Blair

Operator

Hello and thank you for standing by. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Elanco Animal Health Second Quarter 2022 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]

I would now like to turn the conference over to Katy Grissom, Head of Investor Relations. Please, go ahead.

Katy Grissom

Good morning. Thank you for joining us for Elanco Animal Health's second quarter 2022 earnings call. I'm Katy Grissom, Head of Investor Relations. Joining me on today's call are Jeff Simmons, our President and Chief Executive Officer; and Todd Young, our Chief Financial Officer. Today, we're missing Scott Purucker from Investor Relations. He’s enjoying paternity leave after the birth of his daughter in July. Congrats, Scott.

The slides referenced during this call are available on the Investor Relations section of elanco.com. Today's discussion will include forward-looking statements. These statements are based on our current assumptions and expectations and are subject to risks and uncertainties that could cause actual results to differ materially from our forecast. For more information, see the risk factors discussed in today's earnings press release as well as our latest Form 10-K and 10-Q filed with the SEC.

We do not undertake any duty to update any forward-looking statement. Our remarks today will focus on our non-GAAP financial measures. Reconciliations of these non-GAAP measures are included in the appendix of today's slides and in the earnings press release. After our prepared remarks, we'll be happy to take your questions.

I'll now turn the call over to Jeff.

Jeff Simmons

Thanks, Katy. Good morning, everyone. Elanco continues to execute our innovation, productivity and portfolio strategy, while delivering in the second quarter. In particular, our company-wide productivity agenda continued to deliver, and we are pleased with the progress on our innovation pipeline.